Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapyKoichiro Yamamoto, Hisao Ogawa, Kenichi Tsujita et al.|Journal of Cardiology|2010Cited by 100